We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Illumina, Inc. Logo

Illumina, Inc.

At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. The innovative products that we provide are facilitating breakthroughs in many scientific areas, including oncology, reproductive health, genetic disease, precision medicine, agriculture, microbiology, and beyond. The progress we see being made in genomics inspires us to push the boundaries of what is possible so we can create the next generation of genomics solutions.

Latest Content

The Medical Device Innovation Consortium logo above the Horizon Discovery logo.
Product News

Medical Device Innovation Consortium Partners With PerkinElmer's Horizon Discovery To Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics

The Medical Device Innovation Consortium has partnered with PerkinElmer's Horizon Discovery to develop and manufacture somatic reference samples to simplify and support the validation of next-generation sequencing-based cancer diagnostics.
An image of an RNA molecule
Industry Insight

Addressing RNA Research Challenges

In this interview, we hear from Dr. Eliza Small about the current challenges facing RNA therapeutic development and how these challenges can be overcome.
A collection of yam crops on a wooden table.
Industry Insight

Agricultural Grant To Help Breed More Resilient Yams in West Africa

Technology Networks sat down with 2022 Illumina Agricultural Greater Good Initiative Grant winner Dr. Ranjana Bhattacharjee to learn more about her plans to use genomic analysis to improve the productivity and sustainability of yam crops.
Beckman Coulter Life Sciences Accelerates Next Generation Sequencing by Launching the Biomek NGeniuS Next Generation Library Prep System content piece image
Product News

Beckman Coulter Life Sciences Accelerates Next Generation Sequencing by Launching the Biomek NGeniuS Next Generation Library Prep System

Beckman Coulter Life Sciences unleashes the power of next-generation sequencing and makes it more accessible for research labs of all sizes with the launch of the Biomek NGeniuS liquid handling system.
How Automation Can Help Avoid Next Generation Sequencing Errors Amid “The Great Resignation” content piece image
Industry Insight

How Automation Can Help Avoid Next Generation Sequencing Errors Amid “The Great Resignation”

Learn how automation can help to obtain high-quality next generation sequencing research data.
New Approach to Large-Scale Single-Cell Profiling Developed content piece image
News

New Approach to Large-Scale Single-Cell Profiling Developed

A new experimental pipeline has been developed to profile more cell types from different tissues, incorporating machine learning to collate the data and assemble the cell atlas.
Isolation of High Purity Exosomes content piece image
Product News

Isolation of High Purity Exosomes

AMSBIO is a leading supplier of high purity exosomes using isolation methods including traditional differential and gradient ultracentrifugation, immunoaffinity, size exclusion chromatography as well as precipitation / low speed centrifugation.
TATAA Biocenter Partners With Olink To Add High Quality Proteomics With Unrivaled Throughput to Their Multiomics Offering content piece image
Product News

TATAA Biocenter Partners With Olink To Add High Quality Proteomics With Unrivaled Throughput to Their Multiomics Offering

Olink Holding has announced its collaboration with TATAA Biocenter, launching Olink®Explore 3072 proteome profiling service.
Genetic Study of Over 57,000 People Provides Insights Into Severe COVID-19 content piece image
News

Genetic Study of Over 57,000 People Provides Insights Into Severe COVID-19

Some 16 new genetic variants associated with severe Covid-19, including some related to blood clotting, immune response and intensity of inflammation, have been identified.
The Genome in 3D – How Chromatin Conformation Impacts Gene Regulation content piece image
Industry Insight

The Genome in 3D – How Chromatin Conformation Impacts Gene Regulation

Three-dimensional interactions across the genome can impact gene expression, and understanding these interactions could offer new insights into oncogenic mechanisms.
Advertisement